End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.97 CNY | +0.11% | -3.24% | -24.43% |
Apr. 26 | Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023 | CI |
Apr. 25 | Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 857M 118M | Sales 2023 | 667M 92.07M | Capitalization | 2.26B 312M |
---|---|---|---|---|---|
Net income 2022 | 44M 6.07M | Net income 2023 | 15M 2.07M | EV / Sales 2022 | 1.95 x |
Net cash position 2022 | 271M 37.44M | Net cash position 2023 | 375M 51.74M | EV / Sales 2023 | 2.83 x |
P/E ratio 2022 |
44.3
x | P/E ratio 2023 |
148
x | Employees | 439 |
Yield 2022 |
0.98% | Yield 2023 |
0.25% | Free-Float | 62.16% |
1 day | +0.11% | ||
1 week | -3.24% | ||
Current month | +0.67% | ||
1 month | +4.06% | ||
3 months | +7.94% | ||
6 months | -30.09% | ||
Current year | -24.43% |
Managers | Title | Age | Since |
---|---|---|---|
Ke Xu
CEO | Chief Executive Officer | 46 | 09-12-31 |
Min Zhou
DFI | Director of Finance/CFO | 37 | 23-01-31 |
Ling Li
CHM | Chairman | 55 | 20-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hu
BRD | Director/Board Member | 53 | 21-09-12 |
Zhan Zhou
BRD | Director/Board Member | 55 | 14-12-11 |
Qian Jin Li
IRC | Investor Relations Contact | 47 | 04-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 8.97 | +0.11% | 3,274,200 |
24-05-23 | 8.96 | -3.34% | 4,774,505 |
24-05-22 | 9.27 | -0.64% | 3,042,200 |
24-05-21 | 9.33 | -1.06% | 3,429,900 |
24-05-20 | 9.43 | +1.73% | 4,639,400 |
End-of-day quote Shenzhen S.E., May 23, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-24.43% | 231M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 002826 Stock